New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Lexicon Pharmaceuticals Inc.
www.lexpharma.com
Latest From Lexicon Pharmaceuticals Inc.
Deal Watch: Castle Creek Likes Partner Fibrocell Enough To Buy It
Dermatology-focused regenerative medicine firm Fibrocell has been reviewing strategic opportunities for more than a year; April’s FCX-007 license deal with Castle Creek results in buyout.
With $260m Settlement From Sanofi, Lexicon Looks For New Zynquista Partner
Sanofi terminated its alliance for the SGLT1/2 inhibitor Zynquista, giving Lexicon full control of development in type 1 and type 2 diabetes, but it is seeking a new partner ideally with a European footprint.
Q2 Review: Big Pharmas Weigh In On M&A, Pricing Reform
As earnings season reaches its peak, Merck, Lilly, Gilead, Amgen and Sanofi release their second quarter results. Business development remains a dominant theme.
Sanofi And Lexicon Fall Out Over Zynquista, As French Group Exits Diabetes Pact
Lexicon labelled Sanofi’s unilateral decision to exit their alliance ‘invalid’ and said the French drugmaker was thus ‘in breach of contract’. Sanofi said its move was triggered by Phase III trial data studying the dual SGLT1 and SGLT2 inhibitor in type-2 diabetes.
Company Information
- Industry
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Gastrointestinal
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Lexicon Genetics Inc.
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Lexicon Pharmaceuticals Inc.
- Senior Management
-
Lonnel Coats, Pres. & CEO
Jeffrey L Wade, EVP, CFO
Praveen Tyle, PhD, EVP, R&D
Pablo Lapuerta, MD, EVP, CMO - Contact Info
-
Lexicon Pharmaceuticals Inc.
Phone: (281) 863-3000
8800 Technology Forest Pl.
The Woodlands, TX 77381-1160
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lexicon Pharmaceuticals Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice